Evidence map›Paper›PMID 37909232›Full record

ArticleJournal of the International AIDS Society2023

Neurodevelopment among children exposed to HIV and uninfected in sub-Saharan Africa.

Michelle A Bulterys, Irene Njuguna, Mary Mahy, Laurie A Gulaid, Katheen M Powis, Catherine J Wedderburn, Grace John-Stewart

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 5 countries.

Michelle A BulterysDepartment of Epidemiology, University of Washington, Seattle, Washington, USA.
Irene NjugunaDepartment of Global Health, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-4250-3231
Mary MahyUNAIDS, Geneva, Switzerland.ORCID 0000-0001-6023-3023
Laurie A GulaidUNICEF, eastern and southern Africa Regional Office, Nairobi, Kenya.
Katheen M PowisHarvard Medical School, Boston, Massachusetts, USA.
Catherine J WedderburnDepartment of Pediatrics and Child Health and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
Grace John-StewartDepartment of Epidemiology, University of Washington, Seattle, Washington, USA.
University of Washington · USHarvard University · USJoint United Nations Programme on HIV/AIDS · CHUniversity of Cape Town · ZA

Funding

VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
HEU outcomes: population-evaluation and screening strategies (HOPE)R33HD103079 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2022 to 2024
$2.6M
NIAID NIH HHS T32 AI007140NICHD NIH HHS R33 HD103079
6 · The paper itself

Abstract

introductionThe population of 16 million children exposed to HIV and uninfected (CHEU) under 15 years of age continues to expand rapidly, and the estimated prevalence of CHEU exceeds 20% in several countries in sub-Saharan Africa with high HIV prevalence. Some evidence suggests that CHEU experience suboptimal neurodevelopmental outcomes compared to children born to women without HIV. In this commentary, we discuss the latest research on biologic and socio-behavioural factors associated with neurodevelopmental outcomes among CHEU. DISCUSSION: Some but not all studies have noted that CHEU are at risk of poorer neurodevelopment across multiple cognitive domains, most notably in language and motor skills, in diverse settings, ages and using varied assessment tools. Foetal HIV exposure can adversely influence infant immune function, structural brain integrity and growth trajectories. Foetal exposure to antiretrovirals may also influence outcomes. Moreover, general, non-CHEU-specific risk factors for poor neurodevelopment, such as preterm birth, food insecurity, growth faltering and household violence, are amplified among CHEU; addressing these factors will require multi-factorial solutions. There is a need for rigorous harmonised approaches to identify children at the highest risk of delay. In high-burden HIV settings, existing maternal child health programmes serving the general population could adopt structured early child development programmes that educate healthcare workers on CHEU-specific risk factors and train them to conduct rapid neurodevelopmental screening tests. Community-based interventions targeting parent knowledge of optimal caregiving practices have shown to be successful in improving neurodevelopmental outcomes in children and should be adapted for CHEU.

conclusionsCHEU in sub-Saharan Africa have biologic and socio-behavioural factors that may influence their neurodevelopment, brain maturation, immune system and overall health and wellbeing. Multidisciplinary research is needed to disentangle complex interactions between contributing factors. Common environmental and social risk factors for suboptimal neurodevelopment in the general population are disproportionately magnified within the CHEU population, and it is, therefore, important to draw on existing knowledge when considering the socio-behavioural pathways through which HIV exposure could impact CHEU neurodevelopment. Approaches to identify children at greatest risk for poor outcomes and multisectoral interventions are needed to ensure optimal outcomes for CHEU in sub-Saharan Africa.

Indexed as

Biological ProductsHIV InfectionsPregnancy Complications, InfectiousPremature BirthAfrica South of the SaharaChildFemaleHIVHumansInfantInfant, NewbornPregnancyBiological ProductsCHEUchildren who are HIV-exposed uninfectedHEUneurodevelopmentperinatal HIV exposuresub-Saharan Africa

Identifiers

PMID37909232
PMCPMC10618877
OpenAlexW4388110993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.